6Josefsson AM,Magnusson PK, Ylitalo N, et al. Viral load of human papilloma virus 16 as a determinant for development of cervical carcinoma in situ: a nested case-control study. Lancet,2000;355(9222):2189.
7Morice P,Castaigne D,Haie-Meder C, et al. Laparoscopic ovarian transposition for pelvic malignancies: indication and functional outcomes. Fertil Steril,1998;70:956.
8Paraskevaidis E, Kalantaridou SN, Kaponis A ,et al. Surgical management of early stage cervical cancer: ten years experience from one Greek health region. Eur J Gynaecol-Oncol,2002,23(4):341.
二级参考文献8
1[1]Crowther ME. Is the nature of cervical carcinoma changing in young women? Obstet Gynecol Survey, 1995,50: 71.
2[2]Elliott PM,Tattersall MHN,Coppleson M,et al. Changing character of cervical cancer in young women. Br Med J,1989,298:288.
3[1]Smith JR, Boyle DC, Corless DJ,et al. Abdominal radical trachelectomy: a new surgical technique for the conservative management of cervical carcinoma. Br J Obstet Gynaecol,1997,104(10):1196
4[2]Rodriguez M, Guimares O, Rose PG. Radical abdominal trachelectomy and pelvic lymphadenectomy with uterine conservation and subsequent pregnancy in the treatment of early invasive cervical cancer. Am J Obstet Gynecol,2001,185(2):370
5[4]Morice P, Juncker L, Rey A, et al. Ovarian transposition for patients with cervical carcinoma treated by radiosurgical combination. Fertil Steril,2000,74(4):743
6[7]Li C,Samsioe G,Iosif C.Quality of Life in long-time survivors of cervical cancer. Maturitas,1999,32(2):95
2Jemal A, Siegel R, Ward E, etal. Cancer statistics, 2007. CA Cancer J Clin,2007;57(1):43-66.
3Kamangar F, Dores GM, Anderson WF. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol, 2006 ; 24 ( 14 ) : 2137-2150.
4Lau HY, Juang CM, Chen YJ, et al. Aggressive characteristics of cervical cancer in young women in Taiwan.Int J Gynaecol Obstet,2009 : 107(3) :220-223.
5Masumoto N, Fujii T, Ishikawa M, et al. Dominant human papillomavirus 16 infection in cervical neoplasia in young Japanese women~ study of 881 outpatients. Gynecol Oncol, 2004 ;94(2) : 509-514.
6Distefano M, Riccardi S, Capelli G, et al. Quality of life and psychological distress in locally advanced cervical cancer patients administered pre-operative chemoradiotherapy. Gyneeol Oncol, 2008 ; 111 ( 1 ) : 144-150.
7Zivanovic O, Alektiar KM, Sonoda Y, et al. Treatment patterns of FIGO stage I 132 cervical cancer:a single-institution experience of radical hysterectomy with individualized postoperative therapy and definitive radiation therapy. Gynecol Oncoi,2008; 111 (2) :265-270.
8Mat SUlTIUT chemother postoperat B2- Ⅱ B chemother a M, Takeshima N, apy followed by ive chemotherapy but Ota T, et al. Neoadjuvant radical hysterectomy plus no radiotherapy for Stage I cervical cancer--Irinotecan and apy. Gynecol Oncol,2010;119(2) :212-216.
9Bulk S, Visser O, Rozendaal I., et al. Cervical cancer in the Netherlands 1989-1998:decrease of squamous cell carcinoma in older women, increase o{ adenoearclnoma in younger women. Cancer,2005 ;113(6) :1005-1009.
10Touboul C, Uzan C, Mauguen A, etal. Prognostic factors and morbidities after completion surgery in patients undergoing initial chemo-radiation therapy for locally advanced cervical cancer. Oncologist, 2010;15(4) :405-415.
